A detailed history of Essex Woodlands Management, Inc. transactions in Medicinova Inc stock. As of the latest transaction made, Essex Woodlands Management, Inc. holds 1,105,941 shares of MNOV stock, worth $2.4 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
1,105,941
Previous 1,105,941 -0.0%
Holding current value
$2.4 Million
Previous $1.59 Million 45.85%
% of portfolio
0.67%
Previous 0.52%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$2.9 - $6.97 $33,100 - $79,555
-11,414 Reduced 1.02%
1,105,941 $4.11 Million
Q4 2019

Feb 14, 2020

SELL
$6.48 - $8.76 $343,537 - $464,411
-53,015 Reduced 4.53%
1,117,355 $7.53 Million
Q3 2017

Nov 14, 2017

BUY
$4.43 - $6.58 $5.18 Million - $7.7 Million
1,170,370
1,170,370 $7.46 Million

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Essex Woodlands Management, Inc. Portfolio

Follow Essex Woodlands Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Woodlands Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Woodlands Management, Inc. with notifications on news.